US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

946.39

-1.1764-0.12%

Number of Gainers:30

Number of Losers:21

Number of Flat:4

PE:- -

High:948.23

Open:947.25

Low:932.62

Close:947.57

Volume:88.83M

Turnover:1.36B

Market Cap:165.11B

Float Cap:95.61B

Loading ...

MEC Resources Lists 373.5 Million New Options for Shareholders

UBS: LI AUTO-W's L9 Refresh to Catalyze Re-rating, Reiterates "Buy"

Battery Mineral Resources launches up to $25 million LIFE private placement to fund Punitaqui mine

Bremworth Lowers Distribution to Shareholders From Acquisition by Mohawk Industries' Unit; Shares Fall 10%

MT Newswires Live

Stocks to Watch: Goodyear Tire, On Semiconductor, RegenexBio, Upwork

EDU Holdings Sets 2026 Student Enrolment Reporting Timetable

Regenxbio's Gene Therapy for Hunter Syndrome Fails to Win FDA Approval

MT Newswires Live

Director Clint Hurt Reports Disposal of PrimeEnergy Resources Corporation Common Shares

10% Owner Robert de Rothschild Reports Sale of PrimeEnergy Resources Corporation Shares

BRIEF-REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II

Regenxbio falls 21% to $8.10 after FDA issues CRL for BLA for RGX-121

US FDA declines to approve Regenxbio's rare disease drug

Regenxbio says FDA issues CRL regarding BLA for RGX-121

REGENXBIO trading halted, news pending

Regenxbio Inc - FDA Issues Complete Response Letter for Rgx-121

THOMSON REUTERS

Regenxbio Announces Regulatory Update on Rgx-121 Bla for Mps Ii

THOMSON REUTERS

Regenxbio Inc - Plans to Resubmit Bla for Rgx-121

THOMSON REUTERS

Regenxbio Inc - Requests Type a Meeting With FDA to Discuss Rgx-121 Crl

THOMSON REUTERS

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM

Li Auto Shares Fall After JPMorgan Downgrade

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4563/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4563","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","market":"US","secType":"PLATE","nameCN":"Yesterday's Top Gainers","latestPrice":946.39185,"timestamp":1770670799999,"preClose":947.56824,"halted":0,"volume":88827738,"delay":0,"changeRate":-0.001241,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.176392,"latestTime":"02-09 16:00:00 EST","open":947.2453,"high":948.231,"low":932.6205,"amount":1362727362.608745,"amplitude":0.016474,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.403319,"peRate":29.134057,"turnoverRate":0.016767,"increases":30,"decrements":21,"flats":1,"marketCap":165108332893,"floatMarketCap":95606664262},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4563\",,,,,undefined,":{"symbol":"BK4563","high":948.231,"amplitude":0.016474,"preClose":947.56824,"low":932.6205,"pbRate":"2.403319","latestPrice":946.39185,"volume":88827738,"delay":0,"open":947.2453,"prevYearClose":890.65686,"prevWeekClose":947.5682,"prevMonthClose":942.7195,"prevQuarterClose":890.6569,"fiveDayClose":942.3557,"twentyDayClose":924.7065,"sixtyDayClose":933.6515,"secType":"PLATE","market":"US","turnoverRate":0.016767,"peRate":29.134057,"marketCap":165108332893,"floatMarketCap":95606664262,"timestamp":1770670799999,"nameCN":"Yesterday's Top Gainers"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4563\",,,,undefined,":{"bkCode":"BK4563","up":30,"down":21,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4563\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610699723","title":"MEC Resources Lists 373.5 Million New Options for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2610699723","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610699723?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:47","pubTimestamp":1770691670,"startTime":"0","endTime":"0","summary":"The latest update is out from MEC Resources Ltd ( ($AU:MMR) ). MEC Resources Limited has issued a substantial new class of options to its existing ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mec-resources-lists-373-5-million-new-options-for-shareholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mec-resources-lists-373-5-million-new-options-for-shareholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","BK4161","MEC"],"gpt_icon":0},{"id":"1162625812","title":"UBS: LI AUTO-W's L9 Refresh to Catalyze Re-rating, Reiterates \"Buy\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1162625812","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162625812?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:35","pubTimestamp":1770690911,"startTime":"0","endTime":"0","summary":"UBS has released a research report stating that LI AUTO-W's current valuation level is attractive. The stock is trading at a valuation lower than over 95% of the time since its listing, with net cash...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","BK1539","BK1588","BK1587","BK4563","LI","BK4526","BK4555","BK4551","BK4548","BK4099","BK1119","BK4503","02015","BK4588","BK4585","LU1794554557.SGD","EVS.SI","LU1720050803.USD"],"gpt_icon":0},{"id":"2610969582","title":"Battery Mineral Resources launches up to $25 million LIFE private placement to fund Punitaqui mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969582","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610969582?lang=en_us&edition=fundamental","pubTime":"2026-02-10 09:37","pubTimestamp":1770687475,"startTime":"0","endTime":"0","summary":"Battery Mineral Resources ( ($TSE:BMR) ) just unveiled an announcement. Battery Mineral Resources Corp. has launched a non-brokered private placeme...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/battery-mineral-resources-launches-up-to-25-million-life-private-placement-to-fund-punitaqui-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/battery-mineral-resources-launches-up-to-25-million-life-private-placement-to-fund-punitaqui-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LIFE","BK4173","BK4563"],"gpt_icon":0},{"id":"2610662066","title":"Bremworth Lowers Distribution to Shareholders From Acquisition by Mohawk Industries' Unit; Shares Fall 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610662066","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610662066?lang=en_us&edition=fundamental","pubTime":"2026-02-10 07:41","pubTimestamp":1770680510,"startTime":"0","endTime":"0","summary":"Bremworth  said it now expects to pay between NZ$0.20 per share and NZ$0.30 per share to its shareholders, from its deal to be acquired by Floorscape, a unit of New York Stock Exchange-listed Mohawk Industries, via a scheme of arrangement, according to a Tuesday filing with the New Zealand bourse.The company had earlier said it expects to pay between NZ$0.30 and NZ$0.40 per share to its shareholders from the deal, the filing said.The expected total consideration for the scheme is also now reduced to a range of NZ$0.95 to NZ$1.05 per share, from between NZ$1.05 and NZ$1.15 each.The lowered returns and consideration are due to \"difficult\" trading conditions that impacted the company's earnings and its cash position, the filing added.Shares of the company fell 10% in recent Tuesday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MHK","BK4191","LU0205193047.USD","BK4563","BK4585","BK4588","ATER","LU0205194284.USD","BK4095"],"gpt_icon":0},{"id":"2610966235","title":"Stocks to Watch: Goodyear Tire, On Semiconductor, RegenexBio, Upwork","url":"https://stock-news.laohu8.com/highlight/detail?id=2610966235","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610966235?lang=en_us&edition=fundamental","pubTime":"2026-02-10 07:07","pubTimestamp":1770678420,"startTime":"0","endTime":"0","summary":"Goodyear Tire & Rubber logged lower-than-expected adjusted earnings as the company continues to face challenging industry dynamics. Shares fell 9% to $9.54 in after-hours trading on Monday.On Semiconductor's revenue fell in the fourth quarter due to weakness in two of its business units. The stock declined 4.8% to $62.00 after the bell.RegenxBio said the FDA didn't approve its gene therapy RGX-121. Shares dropped 16.6% to $8.60.Upwork's first-quarter outlook came in below Wall Street expectations. The stock slid 24.3% to $14.23.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0724618433.USD","BK4588","IE00BZ199S13.USD","LU1861215975.USD","LU1720051017.SGD","UPWK","LU1861214812.USD","LU1861220033.SGD","LU1854103824.USD","LU2360107325.USD","LU2298322129.HKD","IE00BFMHRM44.USD","BK4512","LU0124384867.USD","BK4505","BK4585","BK4130","LU1861219969.SGD","LU1548497426.USD","LU1854104046.USD","LU0348723411.USD","BK4139","BK4141","IE00BD6J9T35.USD","BK4563","BK4119","RGNX","LU2357305700.SGD","ON","LU1720051108.HKD","LU1978683503.SGD","BK4605","GT"],"gpt_icon":0},{"id":"2610662886","title":"EDU Holdings Sets 2026 Student Enrolment Reporting Timetable","url":"https://stock-news.laohu8.com/highlight/detail?id=2610662886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610662886?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:49","pubTimestamp":1770677371,"startTime":"0","endTime":"0","summary":"An update from EDU Holdings Limited ( ($AU:EDU) ) is now available. EDU Holdings Limited has outlined its 2026 reporting timetable for student enro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/edu-holdings-sets-2026-student-enrolment-reporting-timetable?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/edu-holdings-sets-2026-student-enrolment-reporting-timetable?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4510","BK4509","LU0327786744.USD","BK4535","BK4506","LU0359202008.SGD","LU0823426480.USD","BK4588","BK4526","LU0359201612.USD","LU0370786039.SGD","LU0455707207.USD","LU2242644610.SGD","BK4503","LU0502904849.HKD","BK4204","BK4563","LU0048580855.USD","LU1023057109.AUD","BK4505","LU0823426308.USD","BK4585","BK4531","LU0572944931.SGD"],"gpt_icon":0},{"id":"2610664455","title":"Regenxbio's Gene Therapy for Hunter Syndrome Fails to Win FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2610664455","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610664455?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:47","pubTimestamp":1770677230,"startTime":"0","endTime":"0","summary":"Regenxbio (RGNX) said late Monday the US Food and Drug Administration did not approve its biologics license application for RGX-121 to treat Mucopolysaccharidosis II, an ultra-rare neurodegenerative d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4563","BK4505","RGNX"],"gpt_icon":0},{"id":"2610566497","title":"Director Clint Hurt Reports Disposal of PrimeEnergy Resources Corporation Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2610566497","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610566497?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:40","pubTimestamp":1770676836,"startTime":"0","endTime":"0","summary":"Clint Hurt, Director at PrimeEnergy Resources Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PrimeEnergy Resources Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 09, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL1SpHrq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4213","PNRG"],"gpt_icon":0},{"id":"2610423661","title":"10% Owner Robert de Rothschild Reports Sale of PrimeEnergy Resources Corporation Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2610423661","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610423661?lang=en_us&edition=fundamental","pubTime":"2026-02-10 06:15","pubTimestamp":1770675319,"startTime":"0","endTime":"0","summary":"Robert de Rothschild, a 10% owner, reported a disposal of common shares of PrimeEnergy Resources Corporation. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PrimeEnergy Resources Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL6yVQPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"10% Owner Robert de Rothschild Reports Sale of PrimeEnergy Resources Corporation Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","PNRG","BK4213"],"gpt_icon":0},{"id":"2610690636","title":"BRIEF-REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II","url":"https://stock-news.laohu8.com/highlight/detail?id=2610690636","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610690636?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:53","pubTimestamp":1770674005,"startTime":"0","endTime":"0","summary":"BRIEF-REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS IIFeb 9 (Reuters) - Regenxbio Inc RGNX.O:REGENXBIO ANNOUNCES REGULATORY UPDATE ON RGX-121 BLA FOR MPS IIREGENXBIO INC - FDA ISSUES CO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUAZWNLJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2610661540","title":"Regenxbio falls 21% to $8.10 after FDA issues CRL for BLA for RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2610661540","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610661540?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:50","pubTimestamp":1770673819,"startTime":"0","endTime":"0","summary":"16:47 EST Regenxbio (RGNX) falls 21% to $8.10 after FDA issues CRL for BLA for RGX-121 Published first on TheFly – the ultimate source for real-tim...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-falls-21-to-8-10-after-fda-issues-crl-for-bla-for-rgx-121-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-falls-21-to-8-10-after-fda-issues-crl-for-bla-for-rgx-121-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4505","BK4588","LU1815336091.USD","CRL","BK4530","IE00BFMHRM44.USD","BK4121","RGNX","LU0757428866.USD","BK4139","LU0029874061.USD","BK4563","BK4585","LU0390134368.USD"],"gpt_icon":0},{"id":"2610166613","title":"US FDA declines to approve Regenxbio's rare disease drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2610166613","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610166613?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:11","pubTimestamp":1770671481,"startTime":"0","endTime":"0","summary":"US FDA declines to approve Regenxbio's rare disease drug Feb 9 (Reuters) - Regenxbio RGNX.O said on Monday the U.S. Food and Drug Administration has declined to approve its drug for a rare disease.  (Reporting by Sneha S K; Editing by Alan Barona) ((Sneha.SK@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nL4N3Z51ZI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNX","BK4139","BK4505","BK4563"],"gpt_icon":0},{"id":"2610666270","title":"Regenxbio says FDA issues CRL regarding BLA for RGX-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2610666270","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610666270?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:10","pubTimestamp":1770671428,"startTime":"0","endTime":"0","summary":"Regenxbio (RGNX) announced that the U.S. FDA has issued a Complete Response Letter regarding its Biologics License Application for RGX-121 for the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-says-fda-issues-crl-regarding-bla-for-rgx-121-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-says-fda-issues-crl-regarding-bla-for-rgx-121-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4530","BK4139","BK4505","CRL","RGNX","LU0390134368.USD","BK4121","LU0757428866.USD","BK4563","BK4588","BK4585","LU0029874061.USD","LU0128526141.USD","IE00BFMHRM44.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2610666278","title":"REGENXBIO trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2610666278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610666278?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:05","pubTimestamp":1770671158,"startTime":"0","endTime":"0","summary":"16:01 EST REGENXBIO (RGNX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking finan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenxbio-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenxbio-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNX","BK4505","BK4563","BK4139"],"gpt_icon":0},{"id":"2610665082","title":"Regenxbio Inc - FDA Issues Complete Response Letter for Rgx-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2610665082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610665082?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:05","pubTimestamp":1770671100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUAZWNLJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNX","BK4139","BK4563","BK4505"],"gpt_icon":0},{"id":"2610665038","title":"Regenxbio Announces Regulatory Update on Rgx-121 Bla for Mps Ii","url":"https://stock-news.laohu8.com/highlight/detail?id=2610665038","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610665038?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:05","pubTimestamp":1770671100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUAZWNLJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNX","BK4563","BK4505","BK4139"],"gpt_icon":0},{"id":"2610650886","title":"Regenxbio Inc - Plans to Resubmit Bla for Rgx-121","url":"https://stock-news.laohu8.com/highlight/detail?id=2610650886","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610650886?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:05","pubTimestamp":1770671100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUAZWNLJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","RGNX","BK4505","BK4139"],"gpt_icon":0},{"id":"2610466506","title":"Regenxbio Inc - Requests Type a Meeting With FDA to Discuss Rgx-121 Crl","url":"https://stock-news.laohu8.com/highlight/detail?id=2610466506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610466506?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:05","pubTimestamp":1770671100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nTUAZWNLJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RGNX","BK4139","BK4505","BK4563"],"gpt_icon":0},{"id":"2610652106","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 04:01 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2610652106","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610652106?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:01","pubTimestamp":1770670860,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 04:01 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nAQN2LLFHJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4505","RGNX","BK4139"],"gpt_icon":0},{"id":"2610653226","title":"Li Auto Shares Fall After JPMorgan Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2610653226","media":"MT Newswires Live","labels":["rating"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610653226?lang=en_us&edition=fundamental","pubTime":"2026-02-10 04:34","pubTimestamp":1770669275,"startTime":"0","endTime":"0","summary":"Li Auto (LI) shares fell 3.2% in Monday trading after JPMorgan downgraded the stock to underweight from neutral and cut its price target to $14 from $18.Intraday volume topped 3.96 million shares, compared with the daily average of 4.46 million.Price: 18.37, Change: -0.60, Percent Change: -3.16","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4503","BK4585","BK4555","EVS.SI","BK4551","BK4563","LI","02015","BK4588","BK4548","BK4526","BK4099"],"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":1,"totalSize":287,"code":"91000000","status":"200"}]}}